相关实验视频

Updated: Jun 10, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

提高乳腺癌免疫疗法的有效性,使用一个Smac武装的瘤病毒

Sijia Tang¹, Kristin V Lyles², Yuzhen Wang³

¹Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30302, USA.

|October 16, 2024

概括

工程化Smac武装瘤病毒 (VSV-S) 减少转移并改善三阴性乳腺癌 (TNBC) 模型中的存活率. 与VSV-S和免疫检查点抑制剂 (ICI) 的联合治疗显示出增强TNBC治疗结果的潜力.

科学领域:

瘤治疗性病毒疗法
免疫治疗是一种免疫疗法.
三重阴性乳腺癌 (TNBC) 研究研究

背景情况:

三重阴性乳腺癌 (TNBC) 反应与PD-L1水平和瘤微环境 (TME) 有关.
与野生型VSV相比,工程化Smac武装瘤病毒 (VSV-S) 显示出增强的抗癌疗效.
VSV-S通过减少免疫抑制细胞和增加细胞毒性免疫细胞透来调节TME.

研究的目的:

为了评估VSV-S在TNBC小鼠模型中的疗效.
在转移性TNBC小鼠模型中评估VSV-S与抗PD-1抗体的联合治疗.
描述VS-S治疗引起的作用机制和TME变化.

主要方法:

在 орто托普和转移性TNBC小鼠模型中进行VSV-S治疗.
用VSV-S和抗PD-1抗体进行组合治疗.
评估TME修改,包括免疫细胞透和PD-L1表达.

主要成果:

在TNBC模型中,新辅助VSV-S治疗显著降低了肺转移,并改善了生存率.
VSV-S治疗导致瘤中的PD-L1表达增加.
肺部VSV-S治疗在转移性TNBC中增强了免疫检查点抑制剂 (ICI) 治疗的疗效.

结论:

VSV-S在TNBC中表现出强大的抗转移和增强生存效应.
瘤病毒和ICI的组合对改善TNBC治疗结果具有显著的前景.
用VSV-S针对TME可以与免疫疗法协同作用,以获得更好的治疗反应.

关键词:

这就是Smac.武装的科利斯病毒.组合疗法治疗组合治疗.免疫疗法免疫疗法转移转移转移转移肺部输送是通过肺部进行的.三重阴性乳腺癌是什么瘤微环境是一个微环境.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...